The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist

Journal:
International Journal of Obesity
Published:
DOI:
10.1038/s41366-026-02017-2
Affiliations:
3
Authors:
6
Go to article
Institutions Authors Share
Hadassah Medical Center, HUJI, Israel
3.000000
 0.50
Can-Fite BioPharma, Israel
2.000000
 0.33
BioInsight, Israel
1.000000
 0.17
Interested in Medical Biochemistry and Metabolomics?